XML 135 R104.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Stock Option Activity (Details) - $ / shares
 12 Months Ended
Jun. 30, 2023
Feb. 28, 2023
Dec. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Shares, Granted 42,635 38,026    
Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance     4 years 3 months 10 days  
2022 Plan [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of Shares Common stock options, outstanding at Beginning balance     5,451,968  
Weighted Average Exercise Price, outstanding at Beginning balance     $ 9.56  
Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance     2 years 11 months 23 days 4 years 5 months 4 days
Number of Shares, Granted     22,843  
Weighted Average Exercise Price, Granted     $ 0.35  
Number of Shares, Forfeited     (401,489)  
Weighted Average Exercise Price, Forfeited     $ 7.58  
Number of Shares, Expired     (2,129,646)  
Weighted Average Exercise Price, Expired     $ 9.20  
Number of Shares Common stock options, outstanding at Ending balance     2,943,676 5,451,968
Weighted Average Exercise Price, outstanding at Ending balance     $ 10.03 $ 9.56
Number of Shares Common stock options, exercisable at Ending balance     2,265,249  
Weighted Average Exercise Price, exercisable at Ending balance     $ 10.06  
Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance     3 years 8 months 19 days  
Number of Shares Common stock options, not vested at Ending balance     678,427  
Number of Shares Common stock options, available for future grants at Ending balance [1]     1,338,225  
[1] Common stock available for future issuance under the 2022 Plan represent 1,800,000 of authorized shares; less 422,052 common stock options outstanding and 19,723 restricted stock units outstanding.